3.0.0 6062 2022-02-09T01:42:23Z 2022-02-09T01:42:23Z House HR 2020-03-03 116 [Congressional Record Volume 166, Number 42 (Tuesday, March 3, 2020)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. SCHNEIDER:H.R. 6062.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8 of the U.S. Constitution.[Page H1470]]]> hsif00 Energy and Commerce Committee House Standing Referred to 2020-03-03T15:01:10Z 2020-03-04 Sponsor introductory remarks on measure. (CR H1476) IntroReferral B00100 9 Library of Congress 2020-03-03 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2020-03-03 Introduced in House IntroReferral Intro-H 9 Library of Congress 2020-03-03 Introduced in House IntroReferral 1000 9 Library of Congress S001190 Rep. Schneider, Bradley Scott [D-IL-10] Bradley Schneider D IL Scott 10 N H001071 Rep. Hice, Jody B. [R-GA-10] Jody Hice R GA B. 10 2020-03-03 True S001145 Rep. Schakowsky, Janice D. [D-IL-9] JANICE SCHAKOWSKY D IL D. 9 2020-03-03 True P000096 Rep. Pascrell, Bill, Jr. [D-NJ-9] WILLIAM PASCRELL D NJ J. 9 2020-03-12 False Health Drug safety, medical device, and laboratory regulation Health technology, devices, supplies Health 00 2020-03-03 Introduced in House 2021-01-28T15:02:54Z This bill expands existing requirements relating to supply shortages of life-saving drugs to also apply to life-saving medical devices.

Generally, a manufacturer must (1) notify the Food and Drug Administration (FDA) of supply interruptions in certain circumstances, (2) provide for the expedited review of a new device that may mitigate the shortage, and (3) allow the FDA to authorize the importation of the device for emergency medical care.

]]> To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes. Display Title To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes. Official Title as Introduced To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes. Introduced in House IH Introduced in House 2020-03-03T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr6062ih/xml/BILLS-116hr6062ih.xml 2020-03-04 Sponsor introductory remarks on measure. (CR H1476) text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.